Lung carcinoma is one of the most common human cancers and is estimated to have an
incidence of approximately 2 million new cases per year worldwide with a 20% mortality
rate. Lung cancer represents one of the leading causes of cancer related death in the world.
Of all cancer types to affect the pulmonary system, non-small cell lung carcinoma comprises
approximately 80–85% of all tumors. In the past few decades cytogenetic and advanced
molecular techniques have helped define the genomic landscape of lung cancer, and in the …